Australia's most trusted source of pharma news
Friday, 22 June 2018
Lost Your Access?
Time to listing speeds up
First half of 2018 faster and bigger than previous year.
Katter pressuring Hunt again
Maverick MP has aonother go at pushing for new listings.
Merck promotes new MS data
Will it be thrid time lucky at PBAC?
Aust pharma worth $25b
Latest AIHW report shows more spent outside PBS than inside.
BMS surged under parting MD
PBS cash almost tripled, then fell back under Pfeiffenberger.
Change at the top for MSD
Appoints Australian with strong local experience as new MD.
MA letting industry down
Prominent patient advocate 'bemused' by lack of public presence.
Celgene MD passes away
George Varkanis has died following a battle with cancer.
More staff questioning loyalty
We're more loyal to companies than they are to us some say.
New leader for Sandoz
Insider named to succeed Tillack as country manager.
Roche doing best on 2018 PBS
Seems to have recipe right for winning new listings.
GSK factory's huge payouts
Blow from 2020 closure will be softer for long term workers.
MedAdvisor commits to US punt
Digital meds manager on board with dispensing software outfit.
Hunt no PBS hero says Labor
Industry should get more credit than show-boating minister.
New move in biosim market
Celltrion set to change game with innovative development.
ViiV plans new HIV filings
Data on two-drug regimen looks good for treatment-naive patients.
Consumers try PBAC pressure
Flooding committee with submissions indicates pent up demand.
First generic for LSDP drug
Inborn error of metabolism treatment copied.
Events & Conferences
© 2003 - 2018 Lush Media
Pharma in Focus
Jolly Good Design